Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

We compared the risks of switching to another oral anticoagulant (OAC) and discontinuation of direct oral anticoagulants (DOACs) among elderly patients with nonvalvular atrial fibrillation (NVAF) who were prescribed rivaroxaban or dabigatran versus apixaban. Patients (≥65 years of age) with NVAF pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Appl Thromb Hemost
Main Authors: Baker, Christine L., Dhamane, Amol D., Rajpura, Jigar, Mardekian, Jack, Dina, Oluwaseyi, Russ, Cristina, Rosenblatt, Lisa, Lingohr-Smith, Melissa, Lin, Jay
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829636/
https://ncbi.nlm.nih.gov/pubmed/31418293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619870249
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados